S S Chandragiri1, E Pasol, R M Gallagher. Show Affiliations » 1. Department of Psychiatry and Behavioral Sciences, State University of New York at Stony Brook, USA.
Abstract
Entities: Chemical Gene
Mesh： See more » Angiotensin-Converting Enzyme Inhibitors/administration & dosageAngiotensin-Converting Enzyme Inhibitors/adverse effectsAngiotensin-Converting Enzyme Inhibitors/pharmacokineticsAnti-Inflammatory Agents, Non-Steroidal/administration & dosageAnti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/pharmacokineticsAntimanic Agents/administration & dosageAntimanic Agents/adverse effectsAntimanic Agents/pharmacokineticsAspirin/administration & dosageAspirin/adverse effectsAspirin/pharmacokineticsBipolar Disorder/bloodBipolar Disorder/drug therapyBipolar Disorder/psychologyCalcium Channel Blockers/administration & dosageCalcium Channel Blockers/adverse effectsCalcium Channel Blockers/pharmacokineticsComorbidityDrug InteractionsFatal OutcomeFemaleHumansHypertension/bloodHypertension/drug therapyLisinopril/administration & dosageLisinopril/adverse effectsLisinopril/pharmacokineticsLithium Carbonate/administration & dosageLithium Carbonate/adverse effectsLithium Carbonate/pharmacokineticsMetabolic Clearance Rate/drug effectsMiddle AgedRisk FactorsVerapamil/administration & dosageVerapamil/adverse effectsVerapamil/pharmacokinetics
Substances： See more » Angiotensin-Converting Enzyme InhibitorsAnti-Inflammatory Agents, Non-SteroidalAntimanic AgentsCalcium Channel BlockersLithium CarbonateVerapamilLisinoprilAspirin
Year: 1998 PMID： 9664775 DOI： 10.1016/S0033-3182(98)71345-3
Source DB: PubMed Journal: Psychosomatics ISSN： 0033-3182 Impact factor: 2.386